Abstract
Background
Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent used to prevent and treat
various bleeding complications. In many studies, investigators have evaluated its
utility and safety orally, intravenously, and topically, but few studies have described
the potential benefits of nebulized TXA.
Case Report
We present a case of massive hemoptysis treated with nebulized TXA in the emergency
department (ED) that led to the cessation of bleeding and avoidance of endotracheal
intubation.
Why Should an Emergency Physician Be Aware of This?
In massive hemoptysis, rapidly available nebulized TXA may be considered a therapeutic
option, serving either as primary therapy or as a bridge until other definitive therapies
can be arranged.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Management of hemoptysis is the emergency department.Hosp Physician. 2005; : 53-59
- Diagnosis and management of hemoptysis.Diagn Interv Radiol. 2014; 20: 299-309
- Massive haemoptysis: the definition should be revised.Eur Respir J. 2008; 32: 1131
- Management and prognosis of massive hemoptysis. Recent experience with 120 patients.J Thorac Cardiovasc Surg. 1993; 105: 394
- Tranexamic acid for hemoptysis: a review.Clin Pulm Med. 2017; 24: 69-74
- Inhalable tranexamic acid for haemoptysis treatment.Eur J Pharm Biopharm. 2015; 93: 311-319
- Topical application of tranexamic acid for the reduction of bleeding.Cochrane Database Syst Rev. 2013; : CD010562
- Antifibrinolytic therapy to reduce haemoptysis from any cause.Cochrane Database Syst Rev. 2012; : CD008711
- 1887: hemoptysis controlled with the use of inhaled tranexamic acid: a case series.Crit Care Med. 2016; 44: 547
- Pulmonary hemorrhage: a novel mode of therapy.Respir Med. 2009; 103: 1196-1200
- Inhaled tranexamic acid as an alternative for hemoptysis treatment.Chest. 2016; 149: 604
- Nebulized tranexamic acid as a noninvasive therapy for cancer-related hemoptysis.J Palliat Med. 2015; 18: 1060-1062
- Does tranexamic acid stop haemoptysis?.Interact Cardiovasc Thoracic Surg. 2013; 17: 991-994
Article info
Publication history
Published online: March 01, 2018
Accepted:
January 19,
2018
Received in revised form:
January 3,
2018
Received:
November 2,
2017
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
